Nanoparticle-based approaches for treating restenosis after vascular injury
Percutaneous coronary intervention (PCI) is currently the main method for treating coronary artery stenosis, but the incidence of restenosis after PCI is relatively high. Restenosis, the narrowing of blood vessels by more than 50% of the normal diameter after PCI, severely compromises the therapeuti...
Saved in:
Main Authors: | Liangfeng Zhao (Author), Liuliu Feng (Author), Rong Shan (Author), Yue Huang (Author), Li Shen (Author), Mingliang Fan (Author), Yu Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis
by: Huiru Zhu, et al.
Published: (2022) -
Stress and Vascular Responses: Anti-inflammatory Therapeutic Strategy Against Atherosclerosis and Restenosis After Coronary Intervention
by: Shiro Kitamoto, et al.
Published: (2003) -
Analysis of influencing factors for restenosis after percutaneous transluminal angioplasty in hemodialysis patients
by: Shen Zhan, et al.
Published: (2024) -
Mechanistic exploration of Yiqi Liangxue Shengji prescription on restenosis after balloon injury by integrating metabolomics with network pharmacology
by: Tianshi Mao, et al.
Published: (2023) -
Artificial Zinc-Finger Transcription Factor of A20 Suppresses Restenosis in Sprague Dawley Rats after Carotid Injury via the PPARα Pathway
by: Zhaoyou Meng, et al.
Published: (2017)